An Oxfam resolution before Moderna shareholders received 24 percent o f the nominal vote, or 29 percent o f the independent vote factoring in the 17 percent of the vote share owned by the company s directors and senior executives. A similar resolution before Pfizer shareholders garnered 27 percent o f the vote.